Indacaterol Maleate/Glycopyrronium Bromide

马来酸茚达特罗/格隆溴铵

Report date: 2025/07/31 10:53:42

Base Information

Drug NameIndacaterol Maleate/Glycopyrronium Bromide
Drug Alias Name格隆溴铵/马来酸茚达特罗Indacaterol/NVA-237马来酸茚达特罗格隆溴铵Glycopyrrolate/Indacaterol Maleate格隆溴铵马来酸茚达特罗 +[14] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMuscarinic acetylcholine receptor antagonistsBeta-2 adrenergic receptor agonists
TargetsMuscarinic acetylcholine receptorBeta-2 adrenergic receptor
Therapy Area/IndicationsPulmonary Disease, Chronic Obstructive
Global Approved IndicationsPulmonary Disease, Chronic Obstructive
Approved Indications in ChinaPulmonary Disease, Chronic Obstructive
Original Approved Country/TerritoryEU
Original Approved Date2013/09/18
Country/TerritoryCzechiaBelgiumBulgaria +[54] 
CombinationsYes Indacaterol MaleateGlycopyrronium Bromide
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesNovartis Pharma Ag
China Registration ClassN/A

Develop Information

Active CompaniesHuizheng (Shanghai) Pharmaceutical Technology Co LtdSunovion Pharmaceuticals IncNovartis Pharma Schweiz Ag +[7] 
Inactive CompaniesNovartis Pharma Stein AgBeijing Novartis Pharma Co Ltd
Active IndicationsPulmonary Disease, Chronic Obstructive
Inactive IndicationsN/A

Other Information

ATC CodeR03AL04
Related LinksWikipediaKEGG